GSK to Buy Oncology Drugmaker Tesaro for Us$5.1 Billion
Helps accelerate GSK’s pipeline and commercial capability in oncology. GlaxoSmithKline plc (GSK) has announced it will acquire Tesaro, an oncology-focused company based in Waltham, Massachusetts,...